OpenSecrets.org @OpenSecretsDC
Pharmaceutical companies have taken to Washington in recent weeks to lobby for new pricing mechanisms to accommodate unusual gene therapy treatments for rare diseases - some of which can cost over $1 million. https://t.co/yUZNxetDiN — PolitiTweet.org